New Parkinson's injection enters human safety testing
Disease control
Completed
This early-stage study tested the safety and how the body processes a new drug called HER-096, given as an injection under the skin. It involved two groups: healthy volunteers who received a single dose, and patients with early Parkinson's disease who received multiple doses over…
Phase: PHASE1 • Sponsor: Herantis Pharma Plc. • Aim: Disease control
Last updated Apr 01, 2026 14:43 UTC